Dana-Farber 101
Safety First
Ready Set Resilient
The Road Ahead
Spoiler Alert
100

You’ll want to bookmark this link—it's your gateway to the DFCI Intranet.

100

This simple action remains the single most effective way to prevent the spread of infection to immunocompromised oncology patients.

Hand hygiene

100

This ability helps us adapt, recover, and even grow when faced with adversity, stress, or challenging demands.

Resilience 

100

Get ready to put your skills into action! This is the day of the week dedicated to skills practice during orientation.

Wednesday

100

This term describes cancer that has spread from its original site to another part of the body.

Metastasis

200

Coming soon! This is the official name of DFCI’s future cancer hospital.  

Lavine Bekenstein Cancer Hospital 

200

This patient-safety model shows how harm can occur when weaknesses in multiple layers of defense line up.

Swiss cheese model

200

When it comes to resilience, small things can make a big difference—name one simple practice that can help strengthen yours.  

Micro recovery moments, journaling, finding 3 good things

200

The countdown is on! This is the date our MAH units officially welcome their first patient.

October 19th

200

Unlike traditional chemotherapy, this type of cancer treatment works by helping the patient’s own immune system recognize and attack cancer cells.

Immunotherapy

300

It all started with this physician, whose vision and work helped establish what we now know as Dana-Farber Cancer Institute.

Sidney Farber

300

An oncology patient with an ANC below this value is considered severely neutropenic and at especially high risk for infection.

500 cells/µL?


300

This practice of intentionally focusing on the present moment can help reduce stress and build resilience.

Mindfulness

300

When all our cohorts come together, this is the combined number of years of nursing experience they bring to the bedside.

470+

300

Flushing, itching, hives, shortness of breath, or sudden changes in vital signs during an infusion may be early signs of this potentially serious reaction.

Hypersensitivity Reaction

400

There are five that guide Nursing and Patient Care Services at DFCI—name any two of these Core Values.

Impact, Excellence, Compassion & Respect, Discovery, Access & Inclusion

400

Medication safety comes down to getting the “rights” right—name at least 5 of the 8 that should be verified during medication administration.

patient, medication, route, dose, time, reason, response, documentation 

400

Burnout doesn’t just affect how you feel at work—name three areas it can negatively impact.

Patient safety, personal healthy, mental health, absenteeism, job dissatisfaction

400

This learning method gives you a safe space to apply knowledge, practice clinical decision-making, and learn from mistakes before caring for real patients.

Simulation

400

This commonly used chemotherapy regimen combines 5-FU, leucovorin, and oxaliplatin and is frequently used in the treatment of colorectal cancer.

FOLFOX

500

Fill in what is missing from the Nursing and Patient Care Services Mission: Provide exceptional, compassionate, -------- grounded in research, education, and advocacy to serve the unique needs of patients, caregivers and --------. 

Provide exceptional, compassionate, relationship-based care grounded in research, education, and advocacy to serve the unique needs of patients, caregivers, and communities.

500

In the PAUSE acronym for safe antineoplastic medication administration, this is what the “U” reminds you to do.

Updated labs

500

This practice after a challenging experience can help an individual or team process what happened, identify emotions, and learn together.

Debriefing

500

Throughout orientation, you’ll hear this word again and again—the process of demonstrating that you can safely and effectively perform the skills required for your role.

Competency

500

This life-threatening oncologic complication involves widespread activation of the clotting cascade, resulting in both abnormal clot formation and consumption of platelets and clotting factors—putting the patient at simultaneous risk for thrombosis and bleeding.

Disseminated intravascular coagulation